Lithium: effects in animal models of vanishing white matter are not promising.

"supplementary table 1 raw data"

"Conflict of interest JB is on the board of wFluidx, Inc., owns stock in Orchard Therapeutics, and has consulted for Bluebird bio, Calico Life Sciences, Denali Therapeutics, Enzyvant, and Neurogene. MK and TEMA have a patent PCT/NL2018/050293 on guanabenz in VWM pending to VUmc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Institutes of Health (grant number R33NS109441); the Bray Chair in Child Neurology Research at the University of Utah; and the Brain and Spine Center of Primary Children's Hospital. This study was supported by ZonMW TOP grant 91217006."